0001410939-22-000130.txt : 20221214
0001410939-22-000130.hdr.sgml : 20221214
20221214162819
ACCESSION NUMBER: 0001410939-22-000130
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221213
FILED AS OF DATE: 20221214
DATE AS OF CHANGE: 20221214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gibney Anthony S
CENTRAL INDEX KEY: 0001750132
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 221462441
MAIL ADDRESS:
STREET 1: C/O ACHILLION PHARMACEUTICALS, INC.
STREET 2: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVERIC bio, Inc.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: (609) 474-6755
MAIL ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: Ophthotech Corp.
DATE OF NAME CHANGE: 20070828
4
1
wf-form4_167105328311833.xml
FORM 4
X0306
4
2022-12-13
0
0001410939
IVERIC bio, Inc.
ISEE
0001750132
Gibney Anthony S
C/O IVERIC BIO, INC.
8 SYLVAN WAY
PARSIPPANY
NJ
07054
0
1
0
0
EVP, Chief Business Officer
Common Stock
2022-12-13
4
M
0
6000
0
A
17791
D
Common Stock
2022-12-13
4
M
0
25000
0
A
42791
D
Restricted Stock Units
2022-12-13
4
M
0
6000
0
D
Common Stock
6000.0
0
D
Restricted Stock Units
2022-12-13
4
M
0
25000
0
D
Common Stock
25000.0
75000
D
Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
This total includes 832 shares acquired by the Reporting Person on September 15, 2022, under the Registrant's 2016 Employee Stock Purchase Plan that were not previously reported.
On December 13, 2021, the Reporting Person was granted 6,000 restricted stock units, which vested on the first anniversary of the grant date with respect to 100% of the shares.
Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date.
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Anthony Gibney
2022-12-14